Epitope analysis of HLA-DQ antigens: What does the antibody see?

Transplantation

Volumn 98, Issue 2, 2014, Pages 157-166

  Tambur, Anat R ^a   Rosati, Jimmy ^a   Roitberg, Shirley ^a   Glotz, Denis ^b   Friedewald, John J ^c   Leventhal, Joseph R ^c  

^a Tarry Bldg   (United States)

^b SAINT LOUIS HOSPITAL   (France)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

de novo DSA; Epitope; HLA antibody; HLA DQ

Indexed keywords

EPITOPE; HLA DQ ANTIGEN;

ALLELE; ALPHA CHAIN; ANTIGEN ANTIBODY REACTION; ARTICLE; BETA CHAIN; CLINICAL ARTICLE; EPITOPE MAPPING; FLUORESCENCE ANALYSIS; HUMAN; IMMUNOASSAY; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

BINDING SITES, ANTIBODY; EPITOPE MAPPING; EPITOPES; GRAFT REJECTION; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MODELS, MOLECULAR; PROTEIN CONFORMATION; TREATMENT FAILURE;

EID: 84904615612     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000220     Document Type: Article

References (42)

1. Schwartz BD, Luehrman LK, Lee J, et al. A public antigenic determinant in the HLA-B5 cross-reacting groupVa basis for cross-reactivity and a possible link with Behcet's disease. Hum Immunol 1980; 1: 37.
2. Schwartz BD, Luehrman LK, Lee T, et al. HLA serological cross-reactivity: HLA-B15 has two public antigens. Hum Immunol 1980; 1: 331.
3. Fuller AA, Rodey GE, Parham P, et al. Epitope map of the HLA-B7 CREG using affinity-purified human alloantibody probes. Hum Immunol 1990; 28: 306.
4. Fuller AA, Trevithick JE, Rodey GE, et al. Topographic map of the HLA-A2 CREG epitopes using human alloantibody probes. Hum Immunol 1990; 28: 284.
5. Bjorkman PJ, Strominger JL, Wiley DC. Crystallization and X-ray diffraction studies on the histocompatibility antigens HLA-A2 and HLA-A28 from human cell membranes. J Mol Biol 1985; 186: 205.
6. Saper MA, Bjorkman PJ, Wiley DC. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J Mol Biol 1991; 219: 277.
7. Gorga JC, Brown JH, Jardetzky T, et al. Crystallization of HLA-DR antigens. Res Immunol 1991; 142: 401.
8. Marrari M, Conca R, Pratico-Barbato L, et al. Brief report: why did two patients who type for HLA-B13 have antibodies that react with all Bw4 antigens except HLA-B13? Transpl Immunol 2011; 25: 217.
9. Marrari M, Duquesnoy RJ. Why can sensitization by an HLA-DR2 mismatch lead to antibodies that react also with HLA-DR1? Hum Immunol 2009; 70: 403.
10. Tambur AR, Buckingham M, McDonald L, et al. Development of donor-specific and nonYdonor-specific HLA-DP antibodies post-transplant: the role of epitope sharing and epitope matching. Clin Transpl 2006: 399.
11. Cai J, Terasaki PI, Mao Q, et al. Development of nondonor-specific HLA-DR antibodies in allograft recipients is associated with shared epitopes with mismatched donor DR antigens. Am J Transplant 2006; 6: 2947.
12. Duquesnoy RJ. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. Hum Immunol 2002; 63: 339.
13. Duquesnoy RJ, Marrari M. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of ami-no acid triplet-defined epitopes. Hum Immunol 2002; 63: 353.
14. Duquesnoy RJ, Takemoto S, de Lange P, et al. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A, B amino acid triplet level on kidney transplant survival. Transplantation 2003; 75: 884.
15. Duquesnoy RJ, Howe J, Takemoto S. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients. Transplantation 2003; 75: 889.
16. Duquesnoy RJ, Askar M. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP. Hum Immunol 2007; 68: 12.
17. El-Awar N, Cook D, Terasaki PI. HLA class I epitopes: A and B loci. Clin Transpl 2006: 79.
18. El-Awar N, Terasaki PI, Cai J, et al. Epitopes of the HLA-A, B, C, DR, DQ and MICA antigens. Clin Transpl 2007; 21: 175.
19. El-Awar NR, Akaza T, Terasaki PI, et al. Human leukocyte antigen class I epitopes: update to 103 total epitopes, including the C locus. Transplantation 2007; 84: 532.
20. Van Regenmortel MH, Altschuh D, Chatellier J, et al. Measurement of antigen-antibody interactions with biosensors. J Mol Recognit 1998; 11: 163.
21. Duquesnoy RJ, Mulder A, Askar M, et al. HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes. Hum Immunol 2005; 66: 749.
22. Marrari M, Mostecki J, Mulder A, et al. Human monoclonal antibody reactivity with human leukocyte antigen class I epitopes defined by pairs of mismatched eplets and self-eplets. Transplantation 2010; 90: 1468.
23. Duquesnoy RJ. The antibody response to an HLA mismatch: a model for nonself-self discrimination in relation to HLA epitope immuno-genicity. Int J Immunogenet 2012; 39: 1.
24. Hayakawa K, Asano M, Shinton SA, et al. Positive selection of natural autoreactive B cells. Science 1999; 285: 113.
25. Pillai S, Cariappa A, Moran ST. Positive selection and lineage commitment during peripheral B-lymphocyte development. Immunol Rev 2004; 197: 206.
26. Morris SC, Moroldo M, Giannini EH, et al. In vivo survival of autoreactive B cells: characterization of long-lived B cells. J Immunol 2000; 164: 3035.
27. DeVos JM, Gaber AO, Knight RJ, et al. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation. Kidney Int 2012; 82: 598.
28. Willicombe M, Brookes P, Sergeant R, et al. De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy. Transplantation 2012; 94: 172.
29. Ntokou IS, Iniotaki AG, Kontou EN, et al. Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules. Transpl Int 2011; 24: 1084.
30. Wiebe C, Nickerson P. Posttransplant monitoring of de novo human leukocyte antigen donor-specific antibodies in kidney transplantation. Curr Opin Organ Transplant 2013; 18: 470.
31. Tambur AR, Leventhal JR, Friedewald JJ, et al. The complexity of human leukocyte antigen (HLA)-DQ antibodies and its effect on virtual crossmatching. Transplantation 2010; 90: 1117.
32. Tambur AR, Leventhal JR, Zitzner JR, et al. The DQ barrier: improving organ allocation equity using HLA-DQ information. Transplantation 2013; 95: 635.
33. Tambur AR, Leventhal JR, Walsh RC, et al. HLA-DQ Barrier: effects on cPRA Calculations. Transplantation 2013; 96: 1065.
34. Kosmoliaptsis V, Bradley JA, Sharples LD, et al. Predicting the im-munogenicity of human leukocyte antigen class I alloantigens using structural epitope analysis determined by HLAMatchmaker. Transplantation 2008; 85: 1817.
35. Kosmoliaptsis V, Sharples LD, Chaudhry AN, et al. Predicting HLA class II alloantigen immunogenicity from the number and physi-ochemical properties of amino acid polymorphisms. Transplantation 2011; 91: 183.
36. Kosmoliaptsis V, Dafforn TR, Chaudhry AN, et al. High-resolution, three-dimensional modeling of human leukocyte antigen class I structure and surface electrostatic potential reveals the molecular basis for alloantibody binding epitopes. Hum Immunol 2011; 72: 1049.
37. Lutz CT, Smith KD, Greazel NS, et al. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix. J Immunol 1994; 153: 4099.
38. Arnett KL, Adams EJ, Gumperz JE, et al. Expression of an unusual Bw4 epitope by a subtype of HLA-B8 [B*0802]. Tissue Antigens 1995; 46: 316.
39. Voorter CE, van der Vlies S, Kik M, et al. Unexpected Bw4 and Bw6 reactivity patterns in new alleles. Tissue Antigens 2000; 56: 363.
40. Duquesnoy RJ, Marrari M, Mulder A, et al. Structural aspects of human leukocyte antigen class I epitopes detected by human monoclonal antibodies. Hum Immunol 2012; 73: 267.
41. Cano P, Klitz W, Mack SJ, et al. Common and well-documented HLA alleles: report of the Ad-Hoc committee of the american society for histocompatiblity and immunogenetics. Hum Immunol 2007; 68: 392.
42. Hogue CW. Cn3D: a new generation of three-dimensional molecular structure viewer. Trends Biochem Sci 1997; 22: 314.